Suppr超能文献

2,2'-吡啶异吲哚啉磺酸对重组P2Y1嘌呤受体ATP反应的增强作用。

Potentiation by 2,2'-pyridylisatogen tosylate of ATP-responses at a recombinant P2Y1 purinoceptor.

作者信息

King B F, Dacquet C, Ziganshin A U, Weetman D F, Burnstock G, Vanhoutte P M, Spedding M

机构信息

Department of Anatomy and Developmental Biology, University College London.

出版信息

Br J Pharmacol. 1996 Mar;117(6):1111-8. doi: 10.1111/j.1476-5381.1996.tb16704.x.

Abstract
  1. 2,2'-Pyridylisatogen tosylate (PIT) has been reported to be an irreversible antagonist of responses to adenosine 5'-triphosphate (ATP) at metabotropic purinoceptors (of the P2Y family) in some smooth muscles. When a recombinant P2Y1 purinoceptor (derived from chick brain) is expressed in Xenopus oocytes, ATP and 2-methylthioATP (2-MeSATP) evoke calcium-activated chloride currents (ICl,Ca) in a concentration-dependent manner. The effects of PIT on these agonist responses were examined at this cloned P2Y purinoceptor. 2. PIT (0.1-100 microM) failed to stimulate P2Y1 purinoceptors directly but, over a narrow concentration range (0.1-3 microM), caused a time-dependent potentiation (2-5 fold) of responses to ATP. The potentiation of ATP-responses by PIT was not caused by inhibition of oocyte ecto-ATPase. At high concentrations (3-100 microM), PIT irreversibly inhibited responses to ATP with a IC50 value of 13 +/- 9 microM (pKB = 4.88 +/- 0.22; n = 3). PIT failed to potentiate inward currents evoked by 2-MeSATP and only inhibited the responses to this agonist in an irreversible manner. 3. Known P2 purinoceptor antagonists were tested for their ability to potentiate ATP-responses at the chick P2Y1 purinoceptor. Suramin (IC50 = 230 +/- 80 nM; n = 5) and Reactive blue-2 (IC50 = 580 +/- 130 nM; n = 6) reversibly inhibited but did not potentiate ATP-responses. Coomassie brilliant blue-G (0.1-3 microM) potentiated ATP-responses in three experiments, while higher concentrations (3-100 microM) irreversibly inhibited ATP-responses. The results indicated that potentiation and receptor antagonism were dissociable and not a feature common to all known P2 purinoceptor antagonists. 4. In radioligand binding assays, PIT showed a low affinity (pKi < 5) for a range of membrane receptors, including: alpha 1, alpha 2-adrenoceptors, 5-HT1A, 5-HT1B, 5-HT2, 5-HT3, D1, D2, muscarinic, central benzodiazepine, H1, mu-opioid, dihydropyridine and batrachotoxin receptors. PIT showed some affinity (pKi = 5.3) for an adenosine (A1) receptor. 5. In guinea-pig isolated taenia caeci, PIT (12.5-50 microM) irreversibly antagonized relaxations to ATP (3-1000 microM); PIT also directly relaxed the smooth muscle and histamine was used to restore tone. Relaxations to nicotine (10-100 microM), evoked by stimulating intrinsic NANC nerves of taenia caeci preparations in the presence of hyoscine (0.3 microM) and guanethidine (17 microM), were not affected by PIT (50 microM, for 25-60 min). 6. These experiments indicate that PIT causes an irreversible antagonism of ATP receptors but, for recombinant chick P2Y1 purinoceptors, this effect is preceded by potentiation of ATP agonism. The initial potentiation by PIT (and by Coomassie brilliant blue-G) of ATP-responses raises the possibility of designing a new class of modulatory drugs to enhance purinergic transmission at metabotropic purinoceptors.
摘要
  1. 据报道,2,2'-吡啶异吲哚啉甲苯磺酸盐(PIT)是某些平滑肌中代谢型嘌呤受体(P2Y家族)对三磷酸腺苷(ATP)反应的不可逆拮抗剂。当重组P2Y1嘌呤受体(源自鸡脑)在非洲爪蟾卵母细胞中表达时,ATP和2-甲硫基ATP(2-MeSATP)以浓度依赖的方式诱发钙激活氯电流(ICl,Ca)。在此克隆的P2Y嘌呤受体上研究了PIT对这些激动剂反应的影响。2. PIT(0.1 - 100微摩尔)不能直接刺激P2Y1嘌呤受体,但在狭窄的浓度范围(0.1 - 3微摩尔)内,会引起对ATP反应的时间依赖性增强(2 - 5倍)。PIT对ATP反应的增强不是由抑制卵母细胞胞外ATP酶引起的。在高浓度(3 - 100微摩尔)下,PIT以13±9微摩尔的IC50值不可逆地抑制对ATP的反应(pKB = 4.88±0.22;n = 3)。PIT不能增强由2-MeSATP诱发的内向电流,并且仅以不可逆的方式抑制对该激动剂的反应。3. 测试了已知的P2嘌呤受体拮抗剂增强鸡P2Y1嘌呤受体对ATP反应的能力。苏拉明(IC50 = 230±80纳摩尔;n = 5)和活性蓝-2(IC50 = 580±130纳摩尔;n = 按6)可逆地抑制但不增强ATP反应。考马斯亮蓝-G(0.1 - 3微摩尔)在三个实验中增强了ATP反应,而更高浓度(3 - 100微摩尔)不可逆地抑制ATP反应。结果表明,增强作用和受体拮抗作用是可分离的,并非所有已知的P2嘌呤受体拮抗剂都具有的特征。4. 在放射性配体结合试验中,PIT对一系列膜受体显示出低亲和力(pKi < 5),包括:α1、α2 - 肾上腺素能受体、5-HT1A、5-HT1B、5-HT2、5-HT3、D1、D2、毒蕈碱、中枢苯二氮䓬、H1、μ - 阿片样、二氢吡啶和蛙毒素受体。PIT对腺苷(A1)受体显示出一定亲和力(pKi = 5.3)。5. 在豚鼠离体盲肠带中,PIT(12.5 - 50微摩尔)不可逆地拮抗对ATP(3 - 1000微摩尔)的舒张作用;PIT还直接使平滑肌舒张,并用组胺恢复张力。在存在东莨菪碱(0.3微摩尔)和胍乙啶(17微摩尔)的情况下,刺激盲肠带制剂的内在非肾上腺素能非胆碱能(NANC)神经诱发的对尼古丁(10 - 100微摩尔)的舒张作用不受PIT(50微摩尔,作用25 - 60分钟)影响。6. 这些实验表明,PIT对ATP受体产生不可逆拮抗作用,但对于重组鸡P2Y1嘌呤受体,这种作用之前会出现ATP激动作用的增强。PIT(以及考马斯亮蓝-G)对ATP反应的初始增强增加了设计一类新型调节药物以增强代谢型嘌呤受体处嘌呤能传递的可能性。

相似文献

9

引用本文的文献

本文引用的文献

3
Characterisation of a recombinant P2Y purinoceptor.一种重组P2Y嘌呤受体的特性描述。
Eur J Pharmacol. 1995 Nov 30;291(3):281-9. doi: 10.1016/0922-4106(95)90068-3.
10
Cloning of rat and mouse P2Y purinoceptors.大鼠和小鼠P2Y嘌呤受体的克隆
Biochem Biophys Res Commun. 1995 Jun 6;211(1):211-8. doi: 10.1006/bbrc.1995.1798.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验